Search Results 151-160 of 16284 for monoclonal antibody

1. Teclistamab-cqyv (subcutaneous route) - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

2. Oncology (Medical) - Clinical trials - Mayo Clinic

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

3. Follicular Lymphoma Clinical Trials

   Monoclonal antibodies, such as rituximab, may find cancer cells and help kill them. Radioactive substances linked to monoclonal antibodies can bind to cancer ...

4. Amyloidosis Clinical Trials - Mayo Clinic Research

   ... antibody-drug conjugate (ADC) for the treatment of relapsed or ... Monoclonal antibodies, such as isatuximab, may interfere with the ability of ...

5. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   GA101 is an anti-CD20 humanized and glyco-engineered monoclonal antibody. GA101 has been shown to have increased antibody-dependent cellular cytotoxicity ...

6. Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma - Mayo Clinic

   Monoclonal antibody-drug conjugates, such as brentuximab vedotin, can block cancer growth in different ways by targeting certain cells. Crizotinib and ...

7. Cutaneous B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

   Duvelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab ...

8. Ravulizumab-cwvz (intravenous route) - Mayo Clinic

   Ravulizumab-cwvz injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...

9. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to ...

10. Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) - Mayo Clinic

    ... monoclonal antibody. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...